Dosing and Critical Periods
Exploring the nuances of dosing in psychedelic research reveals a narrow dose-response relationship for reopening critical periods. Short-lived effects, like those from ketamine, lead to brief windows of opportunity, while longer-lasting substances like ibogaine may extend these windows significantly. This insight challenges the pharmaceutical approach, suggesting that psychedelics should be viewed more like surgical interventions rather than conventional medications.In this clip
From this podcast
Tim Ferriss Show
Rethinking Psychedelics, Octopuses on MDMA, and The Master Key of Metaplasticity | Dr. Gül Dölen
Related Questions